BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 33403025)

  • 1. A Double-Edged Sword: The Anti-Cancer Effects of Emodin by Inhibiting the Redox-Protective Protein MTH1 and Augmenting ROS in NSCLC.
    Wahi D; Soni D; Grover A
    J Cancer; 2021; 12(3):652-681. PubMed ID: 33403025
    [No Abstract]   [Full Text] [Related]  

  • 2. TH588, an MTH1 inhibitor, enhances phenethyl isothiocyanate-induced growth inhibition in pancreatic cancer cells.
    Ikejiri F; Honma Y; Kasukabe T; Urano T; Suzumiya J
    Oncol Lett; 2018 Mar; 15(3):3240-3244. PubMed ID: 29435064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MTH1 deficiency selectively increases non-cytotoxic oxidative DNA damage in lung cancer cells: more bad news than good?
    Abbas HHK; Alhamoudi KMH; Evans MD; Jones GDD; Foster SS
    BMC Cancer; 2018 Apr; 18(1):423. PubMed ID: 29661172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MutT Homolog 1 (MTH1) maintains multiple KRAS-driven pro-malignant pathways.
    Patel A; Burton DG; Halvorsen K; Balkan W; Reiner T; Perez-Stable C; Cohen A; Munoz A; Giribaldi MG; Singh S; Robbins DJ; Nguyen DM; Rai P
    Oncogene; 2015 May; 34(20):2586-96. PubMed ID: 25023700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of MTH1 inhibition-induced DNA strand breaks: The slippery slope from the oxidized nucleotide pool to genotoxic damage.
    Rai P; Sobol RW
    DNA Repair (Amst); 2019 May; 77():18-26. PubMed ID: 30852368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MTH1 as a Chemotherapeutic Target: The Elephant in the Room.
    Samaranayake GJ; Huynh M; Rai P
    Cancers (Basel); 2017 May; 9(5):. PubMed ID: 28481306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MTH1 inhibition eradicates cancer by preventing sanitation of the dNTP pool.
    Gad H; Koolmeister T; Jemth AS; Eshtad S; Jacques SA; Ström CE; Svensson LM; Schultz N; Lundbäck T; Einarsdottir BO; Saleh A; Göktürk C; Baranczewski P; Svensson R; Berntsson RP; Gustafsson R; Strömberg K; Sanjiv K; Jacques-Cordonnier MC; Desroses M; Gustavsson AL; Olofsson R; Johansson F; Homan EJ; Loseva O; Bräutigam L; Johansson L; Höglund A; Hagenkort A; Pham T; Altun M; Gaugaz FZ; Vikingsson S; Evers B; Henriksson M; Vallin KS; Wallner OA; Hammarström LG; Wiita E; Almlöf I; Kalderén C; Axelsson H; Djureinovic T; Puigvert JC; Häggblad M; Jeppsson F; Martens U; Lundin C; Lundgren B; Granelli I; Jensen AJ; Artursson P; Nilsson JA; Stenmark P; Scobie M; Berglund UW; Helleday T
    Nature; 2014 Apr; 508(7495):215-21. PubMed ID: 24695224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased MTH1-specific 8-oxodGTPase activity is a hallmark of cancer in colon, lung and pancreatic tissue.
    McPherson LA; Troccoli CI; Ji D; Bowles AE; Gardiner ML; Mohsen MG; Nagathihalli NS; Nguyen DM; Robbins DJ; Merchant NB; Kool ET; Rai P; Ford JM
    DNA Repair (Amst); 2019 Nov; 83():102644. PubMed ID: 31311767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MTH1 as a nucleotide pool sanitizing enzyme: Friend or foe?
    Nakabeppu Y; Ohta E; Abolhassani N
    Free Radic Biol Med; 2017 Jun; 107():151-158. PubMed ID: 27833032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. (S)-crizotinib induces apoptosis in human non-small cell lung cancer cells by activating ROS independent of MTH1.
    Dai X; Guo G; Zou P; Cui R; Chen W; Chen X; Yin C; He W; Vinothkumar R; Yang F; Zhang X; Liang G
    J Exp Clin Cancer Res; 2017 Sep; 36(1):120. PubMed ID: 28882182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cepharanthine synergizes with photodynamic therapy for boosting ROS-driven DNA damage and suppressing MTH1 as a potential anti-cancer strategy.
    Yang ZY; Li LG; Xiong YL; Chen NN; Yu TT; Li HT; Ren T; You H; Wang X; Li TF; Wang MF; Hu J
    Photodiagnosis Photodyn Ther; 2024 Feb; 45():103917. PubMed ID: 38042236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring MTH1 inhibitory potential of Thymoquinone and Baicalin for therapeutic targeting of breast cancer.
    Taiyab A; Choudhury A; Haidar S; Yousuf M; Rathi A; Koul P; Chakrabarty A; Islam A; Shamsi A; Hassan MI
    Biomed Pharmacother; 2024 Apr; 173():116332. PubMed ID: 38430630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. OGG1 co-inhibition antagonizes the tumor-inhibitory effects of targeting MTH1.
    Zhang L; Misiara L; Samaranayake GJ; Sharma N; Nguyen DM; Tahara YK; Kool ET; Rai P
    Redox Biol; 2021 Apr; 40():101848. PubMed ID: 33450725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitor development of MTH1 via high-throughput screening with fragment based library and MTH1 substrate binding cavity.
    Peng C; Li YH; Yu CW; Cheng ZH; Liu JR; Hsu JL; Hsin LW; Huang CT; Juan HF; Chern JW; Cheng YS
    Bioorg Chem; 2021 May; 110():104813. PubMed ID: 33774493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting human MutT homolog 1 (MTH1) for cancer eradication: current progress and perspectives.
    Yin Y; Chen F
    Acta Pharm Sin B; 2020 Dec; 10(12):2259-2271. PubMed ID: 33354500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of MTH1 expression with the tumor malignant potential and poor prognosis in patients with resected lung cancer.
    Fujishita T; Okamoto T; Akamine T; Takamori S; Takada K; Katsura M; Toyokawa G; Shoji F; Shimokawa M; Oda Y; Nakabeppu Y; Maehara Y
    Lung Cancer; 2017 Jul; 109():52-57. PubMed ID: 28577950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human Mut T Homolog 1 (MTH1): a roadblock for the tumor-suppressive effects of oncogenic RAS-induced ROS.
    Rai P
    Small GTPases; 2012; 3(2):120-5. PubMed ID: 22790201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MTH1 expression is required for effective transformation by oncogenic HRAS.
    Giribaldi MG; Munoz A; Halvorsen K; Patel A; Rai P
    Oncotarget; 2015 May; 6(13):11519-29. PubMed ID: 25893378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MutT homologue 1 (MTH1) catalyzes the hydrolysis of mutagenic O6-methyl-dGTP.
    Jemth AS; Gustafsson R; Bräutigam L; Henriksson L; Vallin KSA; Sarno A; Almlöf I; Homan E; Rasti A; Warpman Berglund U; Stenmark P; Helleday T
    Nucleic Acids Res; 2018 Nov; 46(20):10888-10904. PubMed ID: 30304478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of MTH1 activity via mismatch-based DNA chain elongation.
    Gao T; Gu S; Liu F; Li L; Wang Z; Yang J; Li G
    Anal Chim Acta; 2016 Jan; 905():66-71. PubMed ID: 26755138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.